PSC
TEVA icon

Prentiss Smith & Co’s Teva Pharmaceuticals TEVA Stock Holding History

Prentiss Smith & Co’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,200
Closed -$69K – 210
2018
Q3 		$69K Hold
3,200
– – 0.04% 99
2018
Q2 		$78K Hold
3,200
– – 0.05% 93
2018
Q1 		$55K Hold
3,200
– – 0.03% 121
2017
Q4 		$61K Buy
3,200
+2,200
+220% +$33.1K 0.03% 116
2017
Q3 		$18K Hold
1,000
– – 0.01% 169
2017
Q2 		$33K Hold
1,000
– – 0.02% 137
2017
Q1 		$32K Hold
1,000
– – 0.02% 138
2016
Q4 		$36K Buy
+1,000
New +$39.9K 0.02% 136
2013
Q3 		– Sell
-61,496
Closed -$2.41M – 262
2013
Q2 		$2.41M Buy
+61,496
New +$2.39M 1.25% 23

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return